{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:29Z","timestamp":1793325749234,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health","award":["HL147311"],"award-info":[{"award-number":["HL147311"]}]},{"name":"National Institute of Health","award":["HL147311-S1"],"award-info":[{"award-number":["HL147311-S1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00441-022-03704-y","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T03:03:07Z","timestamp":1668481387000},"page":"189-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypertrophic and fibrotic human PKD hearts are associated with macrophage infiltration and abnormal TGF-\u03b21 signaling"],"prefix":"10.1007","volume":"391","author":[{"given":"Farideh","family":"Amirrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-0287","authenticated-orcid":false,"given":"Surya M.","family":"Nauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"3704_CR1","doi-asserted-by":"crossref","unstructured":"Amirrad F, Pala R, Shamloo K, Muntean BS, Nauli SM (2021) Arrhythmogenic hearts in PKD2 mutant mice are characterized by cardiac fibrosis, systolic, and diastolic dysfunctions. Front Cardiovasc Med 8","DOI":"10.3389\/fcvm.2021.772961"},{"key":"3704_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165986","volume":"1867","author":"P Aranguiz","year":"2021","unstructured":"Aranguiz P, Romero P, Vasquez F, Flores-Vergara R, Aravena D, Sanchez G, Gonzalez M, Olmedo I, Pedrozo Z (2021) Polycystin-1 mitigates damage and regulates CTGF expression through AKT activation during cardiac ischemia\/reperfusion. Biochim Biophys Acta Mol Basis Dis 1867:165986","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3704_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1359-6101(03)00044-3","volume":"14","author":"M Azhar","year":"2003","unstructured":"Azhar M, Schultz Jel J, Grupp I, Dorn GW 2nd, Meneton P, Molin DG, Gittenberger-de Groot AC, Doetschman T (2003) Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev 14:391\u2013407","journal-title":"Cytokine Growth Factor Rev"},{"key":"3704_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.kint.2016.04.028","volume":"90","author":"BE Balbo","year":"2016","unstructured":"Balbo BE, Amaral AG, Fonseca JM, de Castro I, Salemi VM, Souza LE, Dos Santos F, Irigoyen MC, Qian F, Chammas R, Onuchic LF (2016) Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout. Kidney Int 90:580\u2013597","journal-title":"Kidney Int"},{"key":"3704_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184\u2013195","journal-title":"Cardiovasc Res"},{"key":"3704_CR6","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.107.704197","volume":"116","author":"M Bujak","year":"2007","unstructured":"Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127\u20132138","journal-title":"Circulation"},{"key":"3704_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman AB, Johnson A, Gabow PA, Schrier RW (1990) The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323:1091\u20131096","journal-title":"N Engl J Med"},{"key":"3704_CR8","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1681\/ASN.V881292","volume":"8","author":"AB Chapman","year":"1997","unstructured":"Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW (1997) Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8:1292\u20131297","journal-title":"J Am Soc Nephrol"},{"key":"3704_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.ekir.2017.05.014","volume":"2","author":"FT Chebib","year":"2017","unstructured":"Chebib FT, Hogan MC, El-Zoghby ZM, Irazabal MV, Senum SR, Heyer CM, Madsen CD, Cornec-Le Gall E, Behfar A, Harris PC, Torres VE (2017) Autosomal dominant polycystic kidney patients may be predisposed to various cardiomyopathies. Kidney Int Rep 2:913\u2013923","journal-title":"Kidney Int Rep"},{"key":"3704_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fphys.2020.00389","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Li Y, Luo J, Hou N (2020) Molecular mechanism of Hippo-YAP1\/TAZ pathway in heart development, disease, and regeneration. Front Physiol 11:389","journal-title":"Front Physiol"},{"key":"3704_CR11","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1128\/MCB.02157-05","volume":"26","author":"X Chen","year":"2006","unstructured":"Chen X, Shevtsov SP, Hsich E, Cui L, Haq S, Aronovitz M, Kerkela R, Molkentin JD, Liao R, Salomon RN, Patten R, Force T (2006) The beta-catenin\/T-cell factor\/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Cell Biol 26:4462\u20134473","journal-title":"Mol Cell Biol"},{"key":"3704_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1750-1172-9-69","volume":"9","author":"WR Cnossen","year":"2014","unstructured":"Cnossen WR, Drenth JP (2014) Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis 9:69","journal-title":"Orphanet J Rare Dis"},{"key":"3704_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD (2019) Autosomal dominant polycystic kidney disease. Lancet 393:919\u2013935","journal-title":"Lancet"},{"key":"3704_CR14","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41588-021-00946-4","volume":"53","author":"K Dong","year":"2021","unstructured":"Dong K, Zhang C, Tian X, Coman D, Hyder F, Ma M, Somlo S (2021) Renal plasticity revealed through reversal of polycystic kidney disease in mice. Nat Genet 53:1649\u20131663","journal-title":"Nat Genet"},{"key":"3704_CR15","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1681\/ASN.V5122048","volume":"5","author":"GM Fick","year":"1995","unstructured":"Fick GM, Johnson AM, Hammond WS, Gabow PA (1995) Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:2048\u20132056","journal-title":"J Am Soc Nephrol"},{"key":"3704_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","volume":"5","author":"J Francisco","year":"2020","unstructured":"Francisco J, Zhang Y, Jeong JI, Mizushima W, Ikeda S, Ivessa A, Oka S, Zhai P, Tallquist MD, Del Re DP (2020) Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition. JACC Basic Transl Sci 5:931\u2013945","journal-title":"JACC Basic Transl Sci"},{"key":"3704_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG (2019) The extracellular matrix in ischemic and nonischemic heart failure. Circ Res 125:117\u2013146","journal-title":"Circ Res"},{"key":"3704_CR18","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/01.hjh.0000165625.79933.9a","volume":"23","author":"P Gosse","year":"2005","unstructured":"Gosse P (2005) Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 23:S27-33","journal-title":"J Hypertens Suppl"},{"key":"3704_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","volume":"6","author":"A Hanna","year":"2019","unstructured":"Hanna A, Frangogiannis NG (2019) The role of the TGF-beta superfamily in myocardial infarction. Front Cardiovasc Med 6:140","journal-title":"Front Cardiovasc Med"},{"key":"3704_CR20","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1073\/pnas.0835895100","volume":"100","author":"S Haq","year":"2003","unstructured":"Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T (2003) Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 100:4610\u20134615","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3704_CR21","first-page":"286","volume":"70","author":"N Hinglais","year":"1994","unstructured":"Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariety J, Michel JB (1994) Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 70:286\u2013294","journal-title":"Lab Invest"},{"key":"3704_CR22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s11248-021-00285-4","volume":"30","author":"X Huang","year":"2021","unstructured":"Huang X, Yan L, Kou S, Meng J, Lu Z, Lin CP, Liu C, Zhang H (2021) Generation and characterization of a Myh6-driven Cre knockin mouse line. Transgenic Res 30:821\u2013835","journal-title":"Transgenic Res"},{"key":"3704_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","volume":"2","author":"CG Iglesias","year":"1983","unstructured":"Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT (1983) Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980. Am J Kidney Dis 2:630\u2013639","journal-title":"Am J Kidney Dis"},{"key":"3704_CR24","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, Karch J, Molkentin JD (2017) Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis. J Clin Invest 127:3770\u20133783","journal-title":"J Clin Invest"},{"key":"3704_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","volume":"118","author":"R Khan","year":"2006","unstructured":"Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10\u201324","journal-title":"Immunology"},{"key":"3704_CR26","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1073\/pnas.040550097","volume":"97","author":"K Kim","year":"2000","unstructured":"Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA (2000) Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A 97:1731\u20131736","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3704_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.RES.0000161999.86198.1e","volume":"96","author":"G Klein","year":"2005","unstructured":"Klein G, Schaefer A, Hilfiker-Kleiner D, Oppermann D, Shukla P, Quint A, Podewski E, Hilfiker A, Schroder F, Leitges M, Drexler H (2005) Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ Res 96:748\u2013755","journal-title":"Circ Res"},{"key":"3704_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549\u2013574","journal-title":"Cell Mol Life Sci"},{"key":"3704_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nrneph.2014.173","volume":"10","author":"CE Kurschat","year":"2014","unstructured":"Kurschat CE, Muller RU, Franke M, Maintz D, Schermer B, Benzing T (2014) An approach to cystic kidney diseases: the clinician\u2019s view. Nat Rev Nephrol 10:687\u2013699","journal-title":"Nat Rev Nephrol"},{"key":"3704_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","volume":"43","author":"F Kuwahara","year":"2004","unstructured":"Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T (2004) Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43:739\u2013745","journal-title":"Hypertension"},{"key":"3704_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature24045","volume":"550","author":"JP Leach","year":"2017","unstructured":"Leach JP, Heallen T, Zhang M, Rahmani M, Morikawa Y, Hill MC, Segura A, Willerson JT, Martin JF (2017) Hippo pathway deficiency reverses systolic heart failure after infarction. Nature 550:260\u2013264","journal-title":"Nature"},{"key":"3704_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.7326\/0003-4819-100-5-683","volume":"100","author":"CV Leier","year":"1984","unstructured":"Leier CV, Baker PB, Kilman JW, Wooley CF (1984) Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med 100:683\u2013688","journal-title":"Ann Intern Med"},{"key":"3704_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1358\/mf.2002.24.6.693065","volume":"24","author":"P Lijnen","year":"2002","unstructured":"Lijnen P, Petrov V (2002) Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol 24:333\u2013344","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"3704_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5603\/CJ.a2016.0087","volume":"24","author":"JC Lin","year":"2017","unstructured":"Lin JC, Kuo WW, Baskaran R, Chen MC, Ho TJ, Chen RJ, Chen YF, Vijaya Padma V, Lay IS, Huang CY (2017) Enhancement of beta-catenin in cardiomyocytes suppresses survival protein expression but promotes apoptosis and fibrosis. Cardiol J 24:195\u2013205","journal-title":"Cardiol J"},{"key":"3704_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.115.303632","volume":"115","author":"Z Lin","year":"2014","unstructured":"Lin Z, von Gise A, Zhou P, Gu F, Ma Q, Jiang J, Yau AL, Buck JN, Gouin KA, van Gorp PR, Zhou B, Chen J, Seidman JG, Wang DZ, Pu WT (2014) Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ Res 115:354\u2013363","journal-title":"Circ Res"},{"key":"3704_CR36","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ (2018) Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci 14:1645\u20131657","journal-title":"Int J Biol Sci"},{"key":"3704_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIRCRESAHA.116.308586","volume":"119","author":"T Matsuda","year":"2016","unstructured":"Matsuda T, Zhai P, Sciarretta S, Zhang Y, Jeong JI, Ikeda S, Park J, Hsu CP, Tian B, Pan D, Sadoshima J, Del Re DP (2016) NF2 activates Hippo signaling and promotes ischemia\/reperfusion injury in the heart. Circ Res 119:596\u2013606","journal-title":"Circ Res"},{"key":"3704_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1536\/ihj.18-514","volume":"60","author":"H Morita","year":"2019","unstructured":"Morita H (2019) Secondary cardiomyopathy in polycystic kidney disease syndrome. Int Heart J 60:10\u201311","journal-title":"Int Heart J"},{"key":"3704_CR39","doi-asserted-by":"publisher","first-page":"F958","DOI":"10.1152\/ajprenal.00489.2011","volume":"301","author":"SM Nauli","year":"2011","unstructured":"Nauli SM (2011) An ACE inhibitor improves vascular outcomes in a PKD model. Am J Physiol Renal Physiol 301:F958","journal-title":"Am J Physiol Renal Physiol"},{"key":"3704_CR40","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","volume":"1812","author":"J Norman","year":"2011","unstructured":"Norman J (2011) Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim Biophys Acta 1812:1327\u20131336","journal-title":"Biochim Biophys Acta"},{"key":"3704_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0002-9440(10)65428-4","volume":"154","author":"AC Ong","year":"1999","unstructured":"Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC (1999) Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 154:1721\u20131729","journal-title":"Am J Pathol"},{"key":"3704_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1021\/acs.nanolett.8b04138","volume":"19","author":"R Pala","year":"2019","unstructured":"Pala R, Mohieldin AM, Shamloo K, Sherpa RT, Kathem SH, Zhou J, Luan Z, Zheng JG, Ahsan A, Nauli SM (2019a) Personalized nanotherapy by specifically targeting cell organelles to improve vascular hypertension. Nano Lett 19:904\u2013914","journal-title":"Nano Lett"},{"key":"3704_CR43","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1021\/acsnano.9b00033","volume":"13","author":"R Pala","year":"2019","unstructured":"Pala R, Mohieldin AM, Sherpa RT, Kathem SH, Shamloo K, Luan Z, Zhou J, Zheng JG, Ahsan A, Nauli SM (2019b) Ciliotherapy: remote control of primary cilia movement and function by magnetic nanoparticles. ACS Nano 13:3555\u20133572","journal-title":"ACS Nano"},{"key":"3704_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1172\/JCI114466","volume":"85","author":"TG Parker","year":"1990","unstructured":"Parker TG, Packer SE, Schneider MD (1990) Peptide growth factors can provoke \u201cfetal\u201d contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85:507\u2013514","journal-title":"J Clin Invest"},{"key":"3704_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1681\/ASN.V131269","volume":"13","author":"Y Pirson","year":"2002","unstructured":"Pirson Y, Chauveau D, Torres V (2002) Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13:269\u2013276","journal-title":"J Am Soc Nephrol"},{"key":"3704_CR46","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","volume":"110","author":"R Querejeta","year":"2004","unstructured":"Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, Martinez Ubago JL, Diez J (2004) Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110:1263\u20131268","journal-title":"Circulation"},{"key":"3704_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000236708","volume":"104","author":"D Riemann","year":"1994","unstructured":"Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J (1994) Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 104:48\u201356","journal-title":"Int Arch Allergy Immunol"},{"key":"3704_CR48","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1681\/ASN.2008080882","volume":"20","author":"RW Schrier","year":"2009","unstructured":"Schrier RW (2009) Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 20:1888\u20131893","journal-title":"J Am Soc Nephrol"},{"key":"3704_CR49","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/ncomms4315","volume":"5","author":"D Shao","year":"2014","unstructured":"Shao D, Zhai P, Del Re DP, Sciarretta S, Yabuta N, Nojima H, Lim DS, Pan D, Sadoshima J (2014) A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun 5:3315","journal-title":"Nat Commun"},{"key":"3704_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1536\/ihj.18-184","volume":"60","author":"Y Suwa","year":"2019","unstructured":"Suwa Y, Higo S, Nakamoto K, Sera F, Kunimatsu S, Masumura Y, Kanzaki M, Mizote I, Mizuno H, Fujio Y, Hikoso S, Sakata Y (2019) Old-age onset progressive cardiac contractile dysfunction in a patient with polycystic kidney disease harboring a PKD1 frameshift mutation. Int Heart J 60:220\u2013225","journal-title":"Int Heart J"},{"key":"3704_CR51","first-page":"H1861","volume":"262","author":"FJ Villarreal","year":"1992","unstructured":"Villarreal FJ, Dillmann WH (1992) Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 262:H1861-1866","journal-title":"Am J Physiol"},{"key":"3704_CR52","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang L, Wu GR, Zhou Q, Yue H, Rao LZ, Yuan T, Mo B, Wang FX, Chen LM, Sun F, Song J, Xiong F, Zhang S, Yu Q, Yang P, Xu Y, Zhao J, Zhang H, Xiong W, Wang CY (2021) MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Sci Adv 7","DOI":"10.1126\/sciadv.abb6075"},{"key":"3704_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002623","volume":"95","author":"TM Yu","year":"2016","unstructured":"Yu TM, Chuang YW, Yu MC, Huang ST, Chou CY, Lin CL, Chiu CC, Kao CH (2016) New-onset atrial fibrillation is associated with polycystic kidney disease: a nationwide population-based cohort study. Medicine (baltimore) 95:e2623","journal-title":"Medicine (baltimore)"},{"key":"3704_CR54","doi-asserted-by":"publisher","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","volume":"304","author":"M Zeisberg","year":"2013","unstructured":"Zeisberg M, Kalluri R (2013) Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol 304:C216-225","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-022-03704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00441-022-03704-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-022-03704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T04:32:21Z","timestamp":1673670741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00441-022-03704-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3704"],"URL":"https:\/\/doi.org\/10.1007\/s00441-022-03704-y","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human-subjects research project was approved by and per accordance with the Chapman University Institutional Review Board (IRB# 1415H040 and FWA#00011020). The approval for tissue procurement was extended to each respective site identified in our IRB application. All retrospective samples from deceased subjects had been previously de-identified by the Department of Pathology and Laboratory Medicine at the UC Los Angeles and UC Irvine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent these studies for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}